Original Article
Retreatment of Tuberculous Patients: An Experience with the Combined Use of High Doses of Isoniazid, Pyrazinamide and Cycloserine
Abstract
Again it is emphasized that treatment resistant organisms are to be avoided by using full dosage of the best chemotherapeutic agents available at the beginning of treatment. Retreatment may need trials of other drugs, but at best is less successful than the original therapy.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
